Everything we've published.

MDMA-Assisted Therapy After the Rejection: Where the Work Stands

A Phase 3 programme produced some of the largest effect sizes in modern psychiatry. The regulator was not persuaded — and what it objected to was not, in the main, the effect size.

Revuelt Health · August 9, 2026 · 10 min read

Acupuncture for Chronic Pain: What the Guidelines Actually Say

A majority of clinical practice guideline recommendations support it. Almost none of them support it strongly. Both facts come from the same review, and the gap between them is the whole story.

Revuelt Health · August 9, 2026 · 9 min read

Hyperbaric Oxygen and the Longevity Claim

A pressurised chamber, sixty sessions, and a telomere finding that launched an industry. The cognitive data is stronger than the anti-ageing data, and it is not the data being sold.

Revuelt Health · August 9, 2026 · 9 min read

Cold Plunges: What the Evidence Says You're Trading

Stress and soreness improve. Muscle protein synthesis does not, and in some studies neither does glucose tolerance. Almost every disagreement in this literature turns out to be a disagreement about timing.

Revuelt Health · August 9, 2026 · 8 min read

Who Actually Shapes Functional Medicine — and What Their Evidence Looks Like

Six figures define the field's centre of gravity. Read against the primary literature, their records are far more uneven than the field's marketing suggests.

Revuelt Health · July 28, 2026 · 12 min read

Treatment-Resistant Lyme in 2026: Where the Evidence Actually Stands

Disulfiram disappointed. Dapsone combinations remain uncontrolled. A vaccine missed its endpoint. A field-by-field account of persistent Lyme, without taking a side it hasn't earned.

Revuelt Health · July 28, 2026 · 13 min read

Updated August 7, 2026